drugset / Trial / NCT07037277
C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to compare the efficacy and safety of BEM/RZR to SOF/VEL in adults with chronic HCV.
Timeline
- Start
- 2025-06-02
- Primary completion
- 2026-12
- Completion
- 2027-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bemnifosbuvir | Other / unclassified | — | Oral |
| Subject | Ruzasvir | Other / unclassified | — | Oral |
| Comparator | Sofosbuvir | Small molecule | — | Oral |
| Comparator | velpatasvir | Other / unclassified | — | Oral |